Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1982 1
1985 1
1986 1
1987 1
1988 3
1990 1
1991 2
1992 1
1994 4
1995 4
1996 3
1997 4
1998 6
1999 11
2000 11
2001 9
2002 18
2003 25
2004 19
2005 44
2006 35
2007 35
2008 45
2009 52
2010 69
2011 91
2012 87
2013 125
2014 140
2015 155
2016 160
2017 175
2018 207
2019 235
2020 322
2021 321
2022 413
2023 422
2024 468
2025 494
2026 415
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,162 results

Results by year

Filters applied: . Clear all
Page 1
Requirements for Human Cerebral Organoids.
Xu YJ, Duan CH, Tang TS, Wang YK, Song W, Fu BQ, Ma AJ, Hu BY, Luo ZG, Zhang XQ, Liu Y, Teng ZQ, Hao J, Wei Q, Wu ZH, Zhang Y, Zhao B, Bian S, Zhang JZ, Peng B, Li TQ, Chen YJ, Liu J, Wang L, Zhao Y, Zhang WQ, Peng YJ, Zhang BY, Bao XJ, Wang YL, Tang Y, Hu SJ, Li Q, Zhu GX, Zhang A, Zhu L, Li QY, Na T, Zhao L, Ping YF, Zhao HL, Niu SS, Zhou Q, Zhao TB, Liu CM. Xu YJ, et al. Among authors: fu bq. Cell Prolif. 2026 May;59(5):e70201. doi: 10.1111/cpr.70201. Epub 2026 Mar 31. Cell Prolif. 2026. PMID: 41914800 Free PMC article. No abstract available.
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial.
Zhou A, Shen P, Li J, Qu W, Wang Z, Ren X, Li Y, Jiang S, Li G, Zeng Y, Qin W, Wu J, Chen P, Zhou F, Guo H, Ji Z, Wang Y, He Z, Wu J, Shi B, Liu L, Yao X, Ma L, Liu Z, Gou X, Fu B, Wang S, Jiang K, Chong T, Tu X, Zhang X, Yu D, Rexiati M, Xue X, Fei J, Wan J, Jia L, He Y, Cui T, Yang AQ, Guo J, Sheng X. Zhou A, et al. Among authors: fu b. Lancet Oncol. 2025 Sep;26(9):1145-1157. doi: 10.1016/S1470-2045(25)00343-2. Lancet Oncol. 2025. PMID: 40907513 Clinical Trial.
Tumour-Derived Extracellular Vesicles Reprogramme Tumour-Associated Macrophages Into Immunosuppressive Phenotype via NOD1 Signalling in Clear Cell Renal Cell Carcinoma.
Pan XW, Li MC, Yang TY, Liu YF, Zhou JL, Tang YF, Zheng HF, Liu JG, Liu ZC, Ma WJ, Li WY, Gong ZX, Zhang S, Zhang HB, Lu BN, Yao YT, Lyu DH, Zhu GY, Zong YB, Yao HL, Zhang AP, Zeng J, Xiong ST, Dong KQ, Zhou W, Fu B, Cui XG. Pan XW, et al. Among authors: fu b. J Extracell Vesicles. 2026 Jun;15(6):e70317. doi: 10.1002/jev2.70317. J Extracell Vesicles. 2026. PMID: 42226559 Free PMC article.
Adaptation to cystine limitation stress confers a targetable lipid metabolism vulnerability in pancreatic ductal adenocarcinoma.
Li Y, Li Z, Li Q, Sun D, Ni B, Tan M, Shay AE, Wang M, Meng C, Shen G, Fu B, Shan Y, Zhang S, Tanshee RR, Zhou T, Xie Y, Chen KM, Qiao B, Dang Y, Kimball SR, Zhang G, Rajacharya GH, Singh PK, Wang X, Hao J, Yang S. Li Y, et al. Among authors: fu b. Nat Commun. 2025 Dec 31;17(1):1343. doi: 10.1038/s41467-025-68099-0. Nat Commun. 2025. PMID: 41476081 Free PMC article.
4,162 results